← Back to Analyst Consensus 
CALC Buy
CalciMedica, Inc.
Current Price —
Implied Upside —
Analysts 9
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 10, 2026 (15 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 20, 2026 | Guggenheim | initiate | — → Buy | — | 52% |
| Mar 5, 2026 | Oppenheimer | maintain | Outperform → Outperform | — | 52% |
| Jan 29, 2026 | HC Wainwright & Co. | downgrade | Buy → Neutral | $0 | 44% |
| May 15, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| Apr 1, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| Mar 4, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| Dec 17, 2024 | LUCID CAPITAL MARKETS | initiate | — → Buy | $13 | 32% |
| Nov 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| Nov 4, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $16 | 44% |
| Aug 13, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Jul 10, 2024 | Oppenheimer | maintain | Outperform → Outperform | $20 | 52% |
| Jul 9, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Jun 27, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| May 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Apr 1, 2024 | Oppenheimer | maintain | Outperform → Outperform | $14 | 52% |
| Apr 1, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Mar 13, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Feb 16, 2024 | JonesTrading | initiate | — → Buy | $22 | 75% |
| Feb 13, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Jan 29, 2024 | HC Wainwright & Co. | initiate | — → Buy | $20 | 44% |
| Nov 13, 2023 | Oppenheimer | reiterate | Outperform → Outperform | $14 | 52% |
| Jul 7, 2023 | EF Hutton | reiterate | Buy → Buy | $17 | 30% |
| Jun 20, 2023 | EF Hutton | initiate | — → Buy | $17 | 30% |
| May 16, 2023 | Oppenheimer | reiterate | — → Outperform | $14 | 52% |
| Mar 24, 2023 | Oppenheimer | initiate | — → Outperform | $14 | 52% |
Price Target Trend
Apr 26, 2026 Latest: $38 Oct 24, 2026
EPS Estimates
0y $-3.02
Lo: $-3.95 Hi: $-2.45
3 analysts ▲1
+1y $-5.30
Lo: $-10.60 Hi: $-2.15
3 analysts 0q $-1.27
Lo: $-1.80 Hi: $-0.75
2 analysts ▲1
+1q $-1.05
Lo: $-1.25 Hi: $-0.85
2 analysts ▲2
Cross-Platform Signals
No cross-platform signals in the last 90 days